Agentix (AGTX) Stock Price, News & Analysis
Company Description
Agentix (OTC Link: AGTX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $801.3K.
AGTX stock has gained 0.0% over the past year. Shares last traded at $0.0200.
On a trailing twelve-month basis, Agentix and diluted earnings per share of $-0.01.
This page provides a comprehensive overview of AGTX stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Agentix (AGTX) stock last traded at $0.0200. At a market capitalization of $801.3K, AGTX is classified as a micro-cap stock with approximately 40.1M shares outstanding.
Latest News
SEC Filings
Agentix has filed 3 recent SEC filings, including 2 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on June 30, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AGTX SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.01. With a current ratio of 0.00, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Agentix (AGTX) currently stands at 13 shares.
Days to Cover History
Days to cover for Agentix (AGTX) currently stands at 1.0 days, down 99.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
AGTX Company Profile & Sector Positioning
Agentix (AGTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.